Results of an aortic endograft trial: Impact of device failure beyond 12 months

Abstract

The clinical outcome at 12 months demonstrated effective aneurysm treatment and comparable safety between EAG repair and COS repair by conventional endpoints. Ongoing follow-up beyond 12 months revealed device-related adverse events that required endograft design changes. Diligent surveillance of outcomes beyond 12 months is necessary to adequately evaluate EAG repair devices.

Increasing Incidence of Midterm and Long-Term Complications After Endovascular Graft Repair of Abdominal Aortic Aneurysms: A Note of Caution Based on a 9-Year Experience

“…Others reported similar results and raised similar concerns. 2,[7][8][9]12,17 Our results expand on these findings and concerns. In our series, the procedural time and blood loss as well as the perioperative death rate (8.5%) were higher than in most other reports.…”

“…Similar concerns have also been raised by others. 2,[7][8][9]12,17,18 In the present study, we analyzed the durability and late complications after EVG repair of AAAs at our institution, where we first used an EVG to treat an AAA in November 1992. 19 …”

A comparison of open conventional and endovascular surgical therapies in abdominal aortic aneurysm repair

“…Değişik çalışmalarda çok farklı oranlar da saptanmıştır. May ve ark.nın [22] çalışmasında %7, Brewster ve ark.nın [23] çalışmasında %21, Zarins ve ark.nın [24] çalışmasında %36, Beebe ve ark.nın [25] çalışmasında %5.6, Becquemin ve ark.nın [19] çalışmasında %27, Jordan ve ark.nın [18] çalışmasında %1.1 ve Lederle ve ark.nın. [16] çalışmasında ise %25 oranında bildirilmiştir.…”

Incidence and Predictors of Clinical Failures Following Catheter-Based Treatment of Abdominal Aortic Aneurysms

“…Most series to date, including this www.intechopen.com report, are dominated by results of earlier, first-generation endografts. (Beebe et al, 2001;Chaikof et al, 2009;Harris et al, 1999;Rutherford & Krupski, 2004). We believe the clinical implications of our study are several.…”